NCT02844322 2026-02-11
BDH-WM01
Institute of Hematology & Blood Diseases Hospital, China
Phase 4 Completed
Clinical Trials
3 trialsNCT02268890 2016-07-11
A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
Johnson & Johnson Taiwan Ltd
Phase 4 Completed
NCT00257114 2008-02-11
Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability
Millennium Pharmaceuticals, Inc.
Phase 4 Completed